|
OTUD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.97179972139372E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23580000011003E-07 |
| Normal-vs-Stage2 |
2.83959999958228E-07 |
| Normal-vs-Stage3 |
2.99239999446144E-08 |
| Normal-vs-Stage4 |
7.27790000043527E-07 |
| Stage1-vs-Stage2 |
1.041570E-01 |
| Stage1-vs-Stage3 |
1.531010E-01 |
| Stage1-vs-Stage4 |
2.962000E-01 |
| Stage2-vs-Stage3 |
6.014200E-01 |
| Stage2-vs-Stage4 |
5.816600E-01 |
| Stage3-vs-Stage4 |
9.560400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.4542000088299E-09 |
| Normal-vs-AfricanAmerican |
3.243100E-03 |
| Normal-vs-Asian |
4.790100E-04 |
| Caucasian-vs-AfricanAmerican |
6.138000E-01 |
| Caucasian-vs-Asian |
3.978800E-01 |
| AfricanAmerican-vs-Asian |
9.105000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91910004449159E-09 |
| Normal-vs-Female |
8.28629997950969E-09 |
| Male-vs-Female |
3.954000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.90429999999709E-06 |
| Normal-vs-Age(41-60Yrs) |
1.07340003552281E-09 |
| Normal-vs-Age(61-80Yrs) |
4.0294999559265E-09 |
| Normal-vs-Age(81-100Yrs) |
2.058400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.471800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.696400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.613800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.027400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.672600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.763800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.301600E-01 |
| Classical-VS-Follicular |
3.86259999995975E-06 |
| Classical-VS-Other |
1.080360E-01 |
| Classical-VS-Normal |
8.48030000000222E-07 |
| Tall-VS-Follicular |
7.450200E-02 |
| Tall-VS-Other |
2.944800E-01 |
| Tall-VS-Normal |
3.009100E-04 |
| Follicular-VS-Other |
9.053000E-01 |
| Follicular-VS-Normal |
2.38029596033584E-11 |
| Other-VS-Normal |
3.296400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.09540212642901E-11 |
| Normal-vs-N1 |
1.50515999999268E-05 |
| N0-vs-N1 |
4.391800E-01 |
|
|
